2023年度
2024年12月27日掲載
2023年度
英文論文
和文原著・著書等
1. 松田能宣.非がん性呼吸器疾患の緩和ケア. 日本内科学会雑誌. 2024;112(3):531-536.
2. 露口一成.結核医療に関する課題. 結核医療の基準とその解説. 2024;
3. 新井徹.呼吸器ジャーナル「慢性間質性肺炎を呈する膠原病の急性増悪の診断と治療」. 膠原病内科 呼吸器内科とリウマチ膠原病内科、見えている景色はどう違うか?. 2024;
4. 茂田光弘.治りにくい肺炎に出会ったときに疑うべき鑑別診断. 臨床雑誌 内科. 2024;133(2):193-7.
5. 田中悠也,倉原優.病気のはなし 結核. 検査と技術. 2024;52(2): 124-128.
6. 新井徹.急性増悪の臨床病態と予後1)特発性肺線維症. 呼吸器内科. 2024;45(1):6~14.
7. 谷向仁,井上真一郎,松田能宣.がん患者におけるせん妄ガイドライン2022年版 -2019年版からの改定ポイントと今後の取り組みについて-. 腫瘍内科. 2024;33(1):65-70.
8. 倉原優.「結核の統計2023」を読み解く. J-IDEO. 2024;8(1):89-91.
9. 倉原優.クロファジミンの処方例が増えてきた. J-IDEO. 2024;8(2):321-323.
10. 合屋将,中野泰,十九浦宏明,高木雄亮,渡邊紘章,松田能宣,角甲純,笠原庸子,小原弘之,森雅紀,中山健夫,山口崇.低酸素血症があり呼吸困難を有する進行性疾患患者に対する高流量鼻カニュラ酸素療法の有効性 システマティックレビュー(原著論文). Palliative Care Research. 2023;18(4):261-269.
11. 西原昂.A Technical Manual of Bronchial Artery Embolization by Coil for Pulmonologists: An Expert's Opinion 呼吸器科医のためのコイルによる気管支動脈塞栓術の技術マニュアル:専門家の意見.Respiratory Endoscopy(一般社団法人 日本呼吸器内視鏡学会). 2023;1(2):28-41.
12. 倉原優.Aspiration Pneumonitis Caused by Gargling with 10% (w/v) Benzalkonium Chloride Proven by Mixing with an Anionic Surfactant 10%(w/v)塩化ベンザルコニウムを用いたうがいによる誤えん性肺炎が,陰イオン界面活性剤と混合することによって証明された1例. Respiratory Endoscopy(一般社団法人 日本呼吸器内視鏡学会). 2023;1(2):75-77.
13. 新井徹.希少疾患. 呼吸器内科学レビュー2024-2025(総合医学社). 2023;
14. 鮫島弘睦.Thoracoscopic sublobar resection for congenital bronchial atresia in adults: a report of three cases. General Thoracic and Cardiovascular Surgery Cases. 2023;
15. 奥田有香麻酔科,栗山俊之,月山淑,松田能宣,山口崇,森雅紀,下川敏雄,川股知之.呼吸困難のコントロールがオピオイドのみでは難しくミダゾラムを併用した終末期がん患者の要因(原著論文). Palliative Care Research. 2023;8(4):247-252.
16. 倉原優.あなどるなかれアミノグリコシドの難聴. J-IDEO. 2023;7(6):896-897.
17. 井上義一.リンパ脈管筋腫症(私の治療). WEB医事新報. 医事新報社. 2023;
18. 松田能宣.身体疾患にともなう抑うつ,不安 呼吸器疾患にともなう抑うつ,不安. 心身医学. 2023;63(6):520-524.
19. 倉原優.Survival 35 喘息発作・COPD増悪のときの全身性ステロイドはいつまで使えばいいの? 研修医サバイバルブック. 2023;
20. 田中悠也,今尾舞,難波晃平,藤本佑樹,池内美貴,山本浩生,橋田恵佑,久米佐知枝,稲尾崇,門田和也,大塚浩二郎,鈴木雄二郎,伊藤利江子,大林千穂.粘液栓の除去のみで軽快したScedosporium apiospermumによるアレルギー性気管支肺真菌症が疑われた1例. アレルギー2023;72(8):1051-1056.
21. 西原昂,石川秀雄.喀血. 救急医学. 2023;47(9):1074-1080.
22. 倉原優.コロナ禍で活躍したハイフロー酸素療法. J-IDEO. 2023;7(5):718-719.
23. 西原昂,石川秀雄.喀血. 救急医学. 2023;47(9):1074-1080.
24. 井上義一. ガイドラインから見るびまん性肺疾患診療の進歩. 肺胞蛋白症診療ガイドライン 2022. ガイドラインから見るびまん性肺疾患診療の進歩. 肺胞蛋白症診療ガイドライン 2022. 2023;44.
25. 井上義一.第5回X線動態画像セミナー総評. インナービジョンP. 2023;12.
26. 丸岡秀一郎,松田能宣,權寧博.ストレス性呼吸器障害をめぐって. 呼吸器内科. 2023;44(2):137-138.
27. 松田能宣.緩和医療とストレス性呼吸障害. 呼吸器内科. 2023;44(2):174-177.
28. 大西幸代.結核におけるリハビリテーションの現状. 医療. 2023;77(4):275-279.
29. 倉原優.薬剤性咳嗽. 呼吸器内科. 2023;44(1):47-52.
30. 倉原優.肺非結核性抗酸菌症 治療指針が11年ぶりに改訂 主要3菌種のポイント. Medical Tribune. 2023;56(15):7.
31. 倉原優.急増する肺非結核性抗酸菌(NTM)症にそなえよ. J-IDEO. 2023;7(4):476-491.
32. 倉原優.アスペルギルス属はなぜアゾール耐性になるのか?. J-IDEO. 2023;7(4):570-581.
33. 倉原優.Book Review シン・感染症999の謎. J-IDEO. 2023;7(4):562.
34. 松田能宣.ようこそ緩和ケアの森 がん・非がん患者の呼吸器症状を診る. 2023;
35. 倉原優.コロナ禍で悩ましい咳をなくしたい. 医療のトリセツ: 36人の専門家が本気で考えたやさしい医療のカタチ. 2023;
36. 所昭宏.不眠のケア. 消化器ナーシング,特集 病態と症状をキソからおさらい! 消化器がんの緩和ケア イラストガイド ; 症状別ケア編. 2023;28(7):673-677.
37. 松田能宣.COPD/間質性肺疾患の呼吸困難に対する症状緩和薬物療法. 進行性疾患患者の呼吸困難の緩和に関する診療ガイドライン2023年版. 2023;86-88.
38. 鮫島弘睦.自然退縮を認めた肺大細胞癌の1例. 肺癌 Japanese journal of Lung Cancer. 2023;63(3):268.
39. 松田能宣.難治性せん妄に対する緩和ケア. がん患者の治療抵抗性の苦痛と鎮静に関する基本的な考え方の手引き2023. 2023;45-56.
40. 松田能宣.これからはじめる非がん患者の緩和ケア第2版. 2023;
41. 澄川裕充.特発性間質性肺炎 特発性肺線維症と進行性肺線維症. 臨床画像. 2023;39(5):494-501.
42. 倉原優.第II章. 結核、非結核性抗酸菌症. 薬剤師のための感染制御マニュアル. 2023;
43. 倉原優.Chapter 6「呼吸器系」. 救急外来 オススメ処方・ダメ処方. 2023;
44. 倉原優、木村仁、大槻登季子、嶋谷泰明、篠原莉奈、雲依美里、藤原綾子、露口一成.結核病棟におけるCOVID-19のアウトブレイク報告. 結核. 2023;98(3):79-84.
45. 倉原優.結核病棟におけるCOVID-19のアウトブレイク報告. 結核. 2023;98(3):78-94.
46. 倉原優.CASE4 COPD. medicina. 2023;60(6):824-9.
47. 倉原優.慢性呼吸器感染症に対する吸入抗菌薬. J-IDEO. 2023;7(3):386-387.
48. 倉原優.ポケット呼吸器診療2023. 2023;
49. 倉原優.2023年新見解に基づく肺MAC症治療とアミカシンリポソーム吸入用懸濁液. medicina. 2023;61(3):480-485.
50. 岡田全司,喜多洋子,露口一成.第2章In vivo遺伝子治療 第5節 感染症in vivo遺伝子治療 2.結核ワクチン. 遺伝子治療開発研究ハンドブック第2版. 2023;489-496.
51. 日本呼吸器学会監修.井上義一(作成委員).特発性肺線維症の治療ガイドライン2023改訂第2版. 特発性肺線維症の治療ガイドライン2023改訂第2版. 2023;
英文論文
- Hoshida Y, Tsujii A, Ohshima S, Saeki Y, Yagita M, Miyamura T, Katayama M, Kawasaki T, Hiramatsu Y, Oshima H, Murayama T, Higa S, Kuraoka K, Hirano F, Ichikawa K, Kurosawa M, Suzuki H, Chiba N, Sugiyama T, Minami Y, Niino H, Ihata A, Saito I, Mitsuo A, Maejima T, Kawashima A, Tsutani H, Takahi K, Kasai T, Shinno Y, Tachiyama Y, Teramoto N, Taguchi K, Naito S, Yoshizawa S, Ito M, Suenaga Y, Mori S, Nagakura S, Yoshikawa N, Nomoto M, Ueda A, Nagaoka S, Tsuura Y, Setoguchi K, Sugii S, Abe A, Sugaya T, Sugahara H, Fujita S, Kunugiza Y, Iizuka N, Yoshihara R, Yabe H, Fujisaki T, Morii E, Takeshita M, Sato M, Saito K, Matsui K, Tomita Y, Furukawa H, Tohma S. Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders. Arthritis & Rheumatology. 2024 45364;(笠井孝彦)
- Kurahara Y, Okamori H, Tsuyuguchi K. A Large Cavity Associated with Pulmonary Infarction. Internal Medicine. 2024 MAR;(倉原優)
- Isobe K, Nakamura Y, Sakamoto S, Tomii K, Takimoto T, Miyazaki Y, Matsumoto M, Sugino K, Ichikado K, Moriguchi S, Yamaguchi K, Baba T, Ozasa H, Igata F, Anabuki K, Homma S, Date H, Suda T, Kishi K. Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia. ERJ Open Research. 2024 45352;10(2):00981-2023.(滝本宜之)
- Molina TJ, Roden AC, Szolkowska M, Shimizu S, Moreira AL, Chalabreysse L, Besse B, de Montpr V, Marom EM, Detterback F, Girard N, Nicholson AG, Marx A. International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study. Lung Cancer. 2024 MAR;189(清水重喜)
- Simon L F Walsh, Jan De Backer, Helmut Prosch, Georg Langs, Lucio Calandriello, Vincent Cottin, Kevin K Brown, Yoshikazu Inoue, Vasilios Tzilas, Elizabeth Estes. Towards the adoption of quantitative computed tomography in the management of interstitial lung disease. European Respiratory Review. 2024 Mar;33(171):(井上義一)
- Akira M, Suganuma N. Clustered Cystic Changes in Long-Term Follow-Up Thin-Section Computed Tomographic Findings in Fibrotic Nonspecific Interstitial Pneumonia. CANADIAN RESPIRATORY JOURNAL. 2024 45336;2024(審良正則)
- Tanaka Y, Kobayashi T, Shimizu S, Kurahara Y. Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug. Internal Medicine. 2024 Feb;(田中悠也)
- Takaaki Hasegawa, Toru Okuyama, Takehiro Uemura, Yoshinobu Matsuda, Hiroyuki Otani, Junichi Shimizu, Yoshitsugu Horio, Naohiro Watanabe, Teppei Yamaguchi, Satoshi Fukuda, Tetsuya Oguri, Ken Maeno, Yoshihiko Taniguchi, Kaname Nosaki, Kensuke Fukumitsu, Tatsuo Akechi. Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer. ONCOLOGIST. 2024 FEB;29(2):e282-e289.(谷口善彦)
- Ryota Shibaki, Daichi Fujimoto, Tsukasa Nozawa, Akira Sano, Yuka Kitamura, Junya Fukuoka, Yuki Sato, Takashi Kijima, Hirotaka Matsumoto, Toshihide Yokoyama, S.atoru Miura, Akito Hata, Motohiro Tamiya, Yoshihiko Taniguchi, Jun Sugisaka, Naoki Furuya, Hisashi Tanaka, Nobuyuki Yamamoto, Yasuhiro Koh, Hiroaki Akamatsu Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer. Journal for immunotherapy of cancer. 2024 FEB;12(2):(谷口善彦)
- Mitsudomi T, Ito H, Okada M, Sugawara S, Shio Y, Tomii K, Okami J, Sakakura N, Kubota K, Takamochi K, Atagi S, Tsuboi M, Oizumi S, Ikeda N, Ohde Y, Ntambwe I, Mahmood J, Cai JL, Tanaka F. Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816. Cancer science. 2024 FEB;115(2):540-554.(安宅信二)
- Satoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, Toshihiro Misumi, Hiroaki Akamatsu, Hiroyasu Shoda, Noriaki Sakakura, Atsushi Nakamura, Yasuhisa Ohde, Hidetoshi Hayashi, Kyoichi Okishio, Morihito Okada, Ichiro Yoshino, Jiro Okami, Kazuhisa Takahashi, Norihiko Ikeda, Masayuki Tanahashi, Yuichi Tambo, Haruhiro Saito, Shinichi Toyooka, Hidetoshi Inokawa, Toyofumi Chen-Yoshikawa, Toshihide Yokoyama, Tatsuro Okamoto, Noriko Yanagitani, Masahide Oki, Makoto Takahama, Kenji Sawa, Hirohito Tada, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Kazuto Nishio. NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study. Molecular Oncology. 2024 FEB;18(2):305-316.(沖塩協一)
- Kagawa T, Kurahashi K, Seki T, Kawasaki Y, Nahara I, Takeda C, Yonekura H, Tanaka S, Kawakami K. The association between intraoperative anesthesia methods used during gastric cancer surgery and long-term mortality: A retrospective observational study using a Japanese claims database. Journal of Anesthesia. 2024 FEB;38(1):92-97.(香川智子)
- Kurahara Y. Tuberculous Bronchostenosis Manifesting as the CT Angiogram Sign. Internal Medicine. 2024 Feb;(倉原優)
- Marlies Wijsenbeek, Jeffrey J Swigris, Yoshikazu Inoue, Michael Kreuter, Toby M Maher, Takafumi Suda, Michael Baldwin, Heiko Mueller, Klaus B Rohr, Kevin R Flaherty. Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis. European Respiratory Journal. 2024 feb;63(2):(井上義一)
- Richeldi L, Schiffman C, Behr J, Inoue Y, Corte TJ, Cottin V, Jenkins RG, Nathan SD, Raghu G, Walsh SLF, Jayia PK, Kamath N, Martinez FJ. Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial. American Journal of Respiratory and Critical Care Medicine. 2024 Feb;209(9):1132-1140.(井上義一)
- Y. Kurahara, Y. Tanaka, T. Kobayashi, S. Yoshida, K. Tsuyuguchi. Efficacy of an oscillating positive expiratory pressure device in patients with Mycobacterium avium complex pulmonary disease. Journal of Infection and Chemotherapy. 2024 Jan;(倉原優)
- Yusuke Okuma, Kaoru Kubota, Mototsugu Shimokawa, Kana Hashimoto, Yosuke Kawashima, Tomohiro Sakamoto, Hiroshi Wakui, Shuji Murakami, Kyoichi Okishio, Kenji Hayashihara, Yuichiro Ohe, Tokyo Cooperative Oncology Group (TCOG). First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial. JAMA oncology. 2024 JAN;10(1):43-51.(沖塩協一)
- Tomioka H, Miyazaki Y, Inoue Y, Egashira R, Kawamura T, Sano H, Johkoh T, Takemura T, Hisada T, Fukuoka J, Comm Japanese Resp Soc Japane. Japanese clinical practice guide 2022 for hypersensitivity pneumonitis. Respiratory Investigation. 2024 JAN;62(1):16-43.(井上義一)
- Akihiro Tamiya. Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors. Respiratory investigation. 2024 JAN;62(1):85-89.(田宮朗裕)
- Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma. Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort. Cancer Research Communications. 2024 JAN;4(1):226-235.(沖塩協一)
- Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase, Kenji Chibana, Kyoichi Kaira, Kyoichi Okishio, Eiki Ichihara, Shuji Murakami, Mototsugu Shimokawa, Nobuyuki Yamamoto. Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L). Therapeutic Advances in Medical Oncology. 2024 JAN;16(沖塩協一)
- Kurahara Y, Shimatani Y, Ryuge M, Tsuyuguchi K. Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae. Internal Medicine. 2024;63(6):879-880.(倉原優)
- Kinnosuke Matsumoto, Takayuki Shiroyama, Motohiro Tamiya, Toshiyuki Minami, Yuhei Kinehara, Akihiro Tamiya, Yasuhiko Suga, Tomoki Kuge, Masahide Mori, Hidekazu Suzuki, Satoshi Tobita, Kiyonobu Ueno, Yoshinobu Namba, Satoshi Tetsumoto, Toshie Niki, Osamu Morimura, Akio Osa, Kazumi Nishino, Izumi Nagatomo, Yoshito Takeda, Takashi Kijima, Atsushi Kumanogoh. Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study. Cancer Immunology Immunotherapy. 2024 JAN;73(1):4.(田宮朗裕)
- Takehiko Kobayashi, Kazunari Tsuyuguchi, Tomoko Kagawa, Toru Arai, Yoshikazu Inoue. Utility of a loop-mediated isothermal amplification detection kit to diagnose chronic pulmonary aspergillosis. Journal of infection and chemotherapy. 2024 JAN;30(1):45484.(小林岳彦)
- Takimoto T, Takeuchi N, Inoue Y, Arai T. Vocal cord palsy in interstitial lung disease: Involvement of architectural distortion by pleuroparenchymal fibroelastosis. Pulmonology. 2024 Jan;(滝本宜之)
- Yoshinobu Matsuda, Hideaki Hasuo, Keiichi Narita, Hiromichi Matsuoka, Ryo Morita, Daisuke Kiuchi Tomoo Ikari, Tetsuo Hori, Koya Okazaki, Kiyohiro Sakai, Sayo Aiki, Hiroko Okabayashi, Shunsuke Oyamada, Keisuke Ariyoshi, Akihiro Tokoro, Mikihiko Fukunaga. Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional study. BMJ Supportive & Palliative Care. 2024 jan;13(3):1126-1123.(松田能宣)
- Okamoto M, Fujimoto K, Johkoh T, Kawaguchi A, Mukae H, Sakamoto N, Ogura T, Ikeda S, Kondoh Y, Yamano Y, Komiya K, Umeki K, Nishikiori H, Tanino Y, Tsuda T, Arai N, Komatsu M, Sakamoto S, Yatera K, Inoue Y, Miyazaki Y, Hashimoto S, Shimizu Y, Hozumi H, Ohnishi H, Handa T, Hattori N, Kishaba T, Kato M, Inomata M, Ishii H, Hamada N, Konno S, Zaizen Y, Azuma A, Suda T, Izuhara K, Hoshino T. A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib. Scientific reports. 2023 45653;13(1):(井上義一)
- Atsushi Yanagisawa, Akihiro Tamiya, Takayuki Takimoto, Hiromitsu Sumikawa. Generalized lymphatic anomaly involving the pleura and bone in an older male: A case report. Respiratory Medicine Case Reports. 2023 DEC;46101961.(柳澤篤)
- Junko Tanizaki, Hiroaki Kuroda, Toshihide Yokoyama, Makoto Takahama, Hiroyasu Shoda, Atsushi Nakamura, Yoshitaka Kitamura, Nobuaki Mamesaya, Yoshihisa Kadota, Kenji Sawa, Kyoichi Okishio, Morihito Okada, Chihiro Suminaka, Kenta Noda, Kazuko Sakai, Yasutaka Chiba, Kazuto Nishio, Kenji Chamoto, Tasuku Honjo, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Hidetoshi Hayashi. Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy. JTO CLINICAL AND RESEARCH REPORTS. 2023 DEC;4(12):(沖塩協一)
- Arai T, Takimoto T, Takeuchi N, Minomo S, Kagawa T, Inoue Y. Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine. 2023 DEC;12(23):(新井徹)
- Morikawa M, Kajiwara K, Kobayashi M, Yusuke K, Nakano K, Matsuda Y, Shimizu Y, Shimazu T, Kako J. Nursing Support for Pain in Patients With Cancer: A Scoping Review. Cureus Journal of Medical Science. 2023 45626;15(11):(松田能宣)
- Samejima H, Kojima K, Fujiwara A, Tokunaga T, Okishio K, Yoon H. The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study. BMC Cancer. 2023 45610;23(1):(鮫島弘睦)
- Kobayashi M, Kajiwara K, Morikawa M, Kanno Y, Nakano K, Matsuda Y, Shimizu Y, Shimazu T, Kako J. Nursing Support for Nausea and Vomiting in Patients With Cancer: A Scoping Review. Cureus Journal of Medical Science. 2023 45599;15(11):(松田能宣)
- Yanagisawa A, Takimoto T, Kurahara Y, Tsuyuguchi K, Yoshida S, Hirose M, Inoue Y, Arai T. A Case of Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection During Sirolimus Therapy. Internal Medicine. 2023 Nov;2847-23.(柳澤篤)
- Hideo Ishikawa, Yu Yamaguchi, Takashi Nishihara, Naoki Omachi, Misaki Ryuge, Kazushi Kitaguchi, Tomoaki Hattori. A Technical Manual of Bronchial Artery Embolization by Coil for Pulmonologists: An Expert's Opinion. Respiratory Endoscopy. 2023 Nov;1(2):28-41.(西原昂)
- Akihiro Tamiya, Kensuke Kanaoka, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Yoshinobu Matsuda, Kyoichi Okishio, Maiko Takeda, Takahiko Kasai, Shigeki Shigeki. Enhancing tumour content and tumour cell count using microdissection contributes to higher detection rate of genetic mutations by next-generation sequencers. Heliyon. 2023 Nov;9(11):(田宮朗裕)
- Kurahara Y, Kanaoka K, Tanaka Y, Maeda Y, Kobayashi T, Takeuchi N, Kagawa T, Tachibana K, Yoshida S, Tsuyuguchi K. Management of dysphonia caused by amikacin liposome inhalation in<i> M.</i><i> avium</i> complex pulmonary disease. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023 45597;27(11):872-873.(倉原優)
- Hironobu Samejima, Naoko Ose, Hideki Nagata, Soichiro Funaki & Yasushi Shintani. Thoracoscopic sublobar resection for congenital bronchial atresia in adults: a report of three cases. General Thoracic and Cardiovascular Surgery Cases. 2023 Nov;(鮫島弘睦)
- Kajiwara K, Kobayashi M, Morikawa M, Kanno Y, Nakano K, Matsuda Y, Shimizu Y, Shimazu T, Kako J. Nursing Support for Caregiver Burden in Family Caregivers of Patients With Cancer: A Scoping Review. American journal of hospice & palliative care. 2023 Nov;13(10):e075024.(松田能宣)
- Hamamoto Y, Kawamura M, Uchida H, Hiramatsu K, Katori C, Asai H, Shimizu S, Egawa S, Yoshida K. The Histological Detection of Ulcerative Colitis Using a No-Code Artificial Intelligence Model. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY. 2023 45590;(清水重喜)
- Minako Shimaya, Yuji Inagaki, Toru Arai, Mayu Kawakami, Naoko Takeuchi, Hiromitsu Sumikawa, Shigeki Shimizu, Takayuki Takimoto, Yoshikazu Inoue. Autoimmune Pulmonary Alveolar Proteinosis Complicated by Myelodysplastic Syndrome: A Case Report. Internal Medicine. 2023 OCT;(島矢未奈子)
- Atagi S, Daimon T, Okishio K, Komuta K, Okano Y, Minato K, Kim YH, Usui R, Tabata C, Tamura A, Kawahara M. A randomized phase III study of docetaxel alone versus docetaxel plus S-1 in patients with previously treated non-small cell lung cancer: JMTO LC09-01. Thoracic cancer. 2023 OCT;14(29):2941-2949.(沖塩協一)
- Kobayashi Y, Arai H, Hamamoto Y, Yoshida K, Shimizu S, Yasuhara Y, Ichimaru N. High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy. CLINICAL GENITOURINARY CANCER. 2023 OCT;21(5):E386-E393.(清水重喜)
- Taniguchi Y, Tamiya A, Matsuda Y, Adachi Y, Enomoto T, Azuma K, Kouno S, Tokoro A, Atagi S. Opioids impair nivolumab outcomes: a retrospective propensity score analysis in non-small-cell lung cancer. BMJ Supportive & Palliative Care. 2023 OCT;13(E1):E185-E189.(谷口善彦)
- Yuhei Kinehara, Takayuki Shiroyama, Akihiro Tamiya, Motohiro Tamiya, Seigo Minami, Masaki Kanazu, Osamu Morimura, Toshie Niki, Satoshi Tetsumoto, Yoshihiko Taniguchi, Tomoki Kuge, Kazumi Nishino, Izumi Nagatomo, Atsushi Kumanogoh, Isao Tachibana. Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC. JTO CLINICAL AND RESEARCH REPORTS. 2023 OCT;4(11):100586.(田宮朗裕)
- Masayuki Imajoh, Shiomi Yoshida, Lisa Nonaka, Yukari Fukushima, Chie Nakajima, Yasuhiko Suzuki, Takayuki Wada. Retrospective identification of pathogenic mycobacterial species in fish: Mycobacterium pseudoshottsii YM-3, isolated from a yellowtail fish in 1986 in Kochi, Japan. Microbiology Resource Announcements. 2023 OCT;12(10):00498-23.(吉田志緒美)
- Fukuda T, Egashira R, Ueno M, Hashisako M, Sumikawa H, Tominaga J, Yamada D, Fukuoka J, Misumi S, Ojiri H, Hatabu H, Johkoh T. Stepwise diagnostic algorithm for high-attenuation pulmonary abnormalities on CT. Insights into Imaging. 2023 OCT;14(1):177.(澄川裕充)
- Kensuke Kanaoka, Hiromitsu Sumikawa, Shunsuke Oyamada, Akihiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Yoshinobu Matsuda, Kyoichi Okishio. Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib. BMC cancer. 2023 Sep;23(1):834.(金岡賢輔)
- Takimoto T, Yanagisawa A, Arai T, Inoue Y. Vocal cord paralysis associated with pleuroparenchymal fibroelastosis: A case report and literature review. Respiratory Investigation. 2023 Sep;61(5):548-552.(滝本宜之)
- Matsuda Y, Tanimukai H, Inoue S, Hirayama T, Kanno Y, Kitaura Y, Inada S, Sugano K, Yoshimura M, Harashima S, Wada S, Hasegawa T, Okamoto Y, Dotani C, Takeuchi M, Kako J, Sadahiro R, Kishi Y, Uchida M, Ogawa A, Inagaki M, Okuyama T. A revision of JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023 45534;53(9):808-822.(松田能宣)
- Kataoka K, Oda K, Takizawa H, Ogura T, Miyamoto A, Inoue Y, Akagawa S, Hashimoto S, Kishaba T, Sakamoto K, Hamada N, Kuwano K, Nakayama M, Ebina M, Enomoto N, Miyazaki Y, Atsumi K, Izumi S, Tanino Y, Ishii H, Ohnishi H, Suda T, Kondoh Y. Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy. Scientific reports. 2023 45526;13(1):(井上義一)
- Kurahara Y, Tsuyuguchi K. Aspiration Pneumonitis Caused by Gargling with 10% (w/v) Benzalkonium Chloride Proven by Mixing with an Anionic Surfactant. Respiratory Endoscopy. 1(2):75-77.(倉原優)
- Atsushi Yanagisawa, Takayuki Takimoto, Ryota Shintani, Takehiko Kobayashi, Masaki Hirose, Toru Arai, Yoshikazu Inoue. Autoimmune Pulmonary Alveolar Proteinosis That Improved after a COVID-19 Episode. Internal Medicine. 2023 AUG;62(15):2237-2241.(柳澤篤)
- Takehiko Kobayashi, Kazunari Tsuyuguchi, Shiomi Yoshida, Toru Arai, Yoshikazu Inoue. Cases of severe Mycobacterium avium lung disease occurred in a married couple caused by identical strain. Journal of infection and chemotherapy. 2023 AUG;29(8):812-815.(小林岳彦)
- Takagi Y, Sato J, Yamamoto Y, Matsunuma R, Watanabe H, Mori M, Hasegawa T, Matsuda Y, Kako J, Kasahara Y, Goya S, Kohara H, Nakayama T, Yamaguchi T. Opioids for the management of dyspnea in cancer patients: a systematic review and meta-analysis. International Journal of Clinical Oncology. 2023 AUG;28(8):999-1010.(松田能宣)
- Shunichi Sugawara, Kentaro Tanaka, Fumio Imamura, Nobuyuki Yamamoto, Makoto Nishio, Kyoichi Okishio, Tomonori Hirashima, Hiroshi Tanaka, Tatsuro Fukuhara, Yasuharu Nakahara, Takayasu Kurata, Nobuyuki Katakami, Morihito Okada, Hidehito Horinouchi, Hibiki Udagawa, Kazuo Kasahara, Miyako Satouchi, Hideo Saka, Takaaki Tokito, Yukio Hosomi, Keisuke Aoe, Kazuma Kishi, Kadoaki Ohashi, Takuma Yokoyama, Noriaki Adachi, Kazuo Noguchi, Paul Schwarzenberger, Terufumi Kato. Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407. Cancer science. 2023 AUG;114(8):3330-3341.(沖塩協一)
- Sadahiro R, Hatta K, Yamaguchi T, Masanori E, Matsuda Y, Ogawa A, Iwata Y, Tokoro A, Nakahara R, Hirayama T, Yanai Y, Ogawa Y, Kayano A, Ariyoshi K, Oyamada S, Uchitomi Y, Akechi T, Yamamoto N, Okita N, Yorikane E, Shimada K, Furukawa T, Hashimoto H, Maeda M, Sato T, Sekimoto A, Sasaki C, Saito E, Uezono Y, Matsuoka H. A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103. JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023 Aug;53(9):851-857.(松田能宣)
- Mori M, Yamaguchi T, Suzuki K, Matsuda Y, Matsunuma R, Watanabe H, Ikari T, Matsumoto Y, Imai K, Yokomichi N, Miwa S, Yamauchi T, Okamoto S, Inoue S, Inoue A, Hui D, Morita T, Satomi E. Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2023 Aug;66(2):e177-e184.(松田能宣)
- Jun Kako, Miharu Morikawa, Masamitsu Kobayashi, Yusuke Kanno, Kohei Kajiwara, Kimiko Nakano, Yoshinobu Matsuda, Yoichi Shimizu, Megumi Hori, Mariko Niino, Miho Suzuki, Taichi Shimazu. Nursing support for breathlessness in patients with cancer: a scoping review. BMJ Open. 2023 Oct;13(10):(松田能宣)
- Kanaoka K, Minami S. Elevation of serum lactate dehydrogenase during methylprednisolone pulse therapy as a predictor of high mortality in acute respiratory failure: A single-center, retrospective study. SAGE Open Medicine. 2023 Aug;(金岡賢輔)
- Yu Kurahara, Yasuaki Shimatani. Melanoptysis. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE. 2023 JUL;116(7):540-541.(倉原優)
- Shimokawa T, Okamoto H, Machida R, Misumi Y, Hosomi Y, Yoneshima Y, Tanaka H, Okishio K, Simizu J, Goto K, Akamatsu H, Kubota K, Nakagawa K, Horinouchi H, Ando M, Kataoka T, Ohe Y. Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial. Lung Cancer. 2023 JUL;181(沖塩協一)
- Yusuke Okuma, Shogo Nomura, Kiichiro Ninomiya, Hiroshi Gyotoku, Shuji Murakami, Yoshihito Kogure, Daijiro Harada, Kyoichi Okishio, Hiroaki Okamoto, Yasushi Goto. Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study). Future Oncology. 2023 JUL;19(22):1515-1521.(沖塩協一)
- T. Arai, Y. Kurahara, M. Moda, T. Kobayashi, Y. Matsuda, T. Kagawa, R. Sugawara, K. Tsuyuguchi, Y. Inoue. COVID-19 in Patients with Pre-Existing Interstitial Lung Disease: Potential Value of a Steroid-Based Treatment Strategy. Journal of Clinical Medicine. 2023 JUL;12(15):4940.(新井徹)
- Khor YH, Cottin V, Holland AE, Inoue Y, McDonald VM, Oldham J, Renzoni EA, Russell AM, Strek ME, Ryerson CJ. Treatable traits: a comprehensive precision medicine approach in interstitial lung disease. European Respiratory Journal. 2023 45474;62(1):(井上義一)
- Hasegawa T, Ochi T, Goya S, Matsuda Y, Kako J, Watanabe H, Kasahara Y, Kohara H, Mori M, Nakayama T, Yamaguchi T. Efficacy of supplemental oxygen for dyspnea relief in patients with advanced progressive illness: A systematic review and meta-analysis. Respiratory Investigation. 2023 Jul;61(4):418-437.(松田能宣)
- Otani H, Amano K, Morita T, Miura T, Mori N, Tatara R, Kessoku T, Tokoro A, Tagami K, Mori M, Taniyama T, Nakajima N, Nakanishi E, Kako J, Miyashita M. Difficulty swallowing and food bolus obstruction in advanced cancer: association with the cachexia-related quality of life. Annals of Palliative Medicine. 2023 Jul;12(4):717-728.(所昭宏)
- Tetsuya Komatsu, Kenji Ohya, Atsushi Ota, Yukiko Nishiuchi, Hirokazu Yano, Kayoko Matsuo, Justice Opare Odoi, Shota Suganuma, Kotaro Sawai, Akemi Hasebe, Tetsuo Asai, Tokuma Yanai, Hideto Fukushi, Takayuki Wada, Shiomi Yoshida, Toshihiro Ito, Kentaro Arikawa, Mikihiko Kawai, Manabu Ato, Anthony D. Baughn, Tomotada Iwamoto, Fumito Maruyama. Unique genomic sequences in a novel Mycobacterium avium subsp. hominissuis lineage enable fine scale transmission route tracing during pig movement. One Health. 2023 JUN;16100559.(吉田志緒美)
- Mori M, Miwa S, Ikari T, Kako J, Hasegawa T, Matsunuma R, Suzuki K, Matsuda Y, Watanabe H, Morita T, Yamaguchi T. Current Management Options for Dyspnea in Cancer Patients. Current Treatment Options in Oncology. 2023 Jun;24(6):565-579.(松田能宣)
- Felix Chua 1, Suying Low 2, Gin Tsen Chai 3, Yoshikazu Inoue 4, Voon Ong 5, Amornpun Wongkarnjana 6, Kamon Kawkitinarong 6, Jin Woo Song 7, Zuhanis Abdul Hamid 8, Aida Abdul Aziz 9, Mae Campomanes 10, Toby M Maher 11, Philip L Molyneaux 12, Syazatul Syakirin. Knowledge gaps in fibrotic interstitial lung disease in pan-Asian populations: data not missing at random?. Lancet Respiratory Medicine. 2023 Jun;11(6):502-504.(井上義一)
- Imai K, Morita T, Mori M, Kiuchi D, Yokomichi N, Miwa S, Okamoto S, Yamauchi T, Naito AS, Matsuda Y, Maeda I, Sugano K, Ikenaga M, Inoue S, Satomi E. Visualizing How to Use Antipsychotics for Agitated Delirium in the Last Days of Life. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2023 JUN;65(6):479-489.(松田能宣)
- Goto Y, Kenmotsu H, Tamiya M, Murakami S, Kurata T, Yanagitani N, Taniguchi H, Kuyama S, Shimizu J, Yokoyama T, Shimada N, Maeda T, Tamiya A, Uchiyama A, Imaizumi K, Takahama T, Kato T, Hayashi H, Shiraiwa N, Toyoizumi S, Kikkawa H, Thomaidou D, Nishio M. A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan. JTO CLINICAL AND RESEARCH REPORTS. 2023 MAY;4(5):100508.(田宮朗裕)
- Yuji Inagaki. Factors Other Than Low-Dose Computed Tomography Screening Related to Stage Shift and Improved Survival of Lung Cancer. Journal of Thoracic Oncology. 2023 MAY;18(5):e48-e49.(稲垣雄士)
- Tomoki Kuge, Takayuki Shiroyama, Akihiro Tamiya, Motohiro Tamiya, Masaki Kanazu, Yuhei Kinehara, Tsunehiro Tanaka, Osamu Morimura, Yoshihiko Taniguchi, Toshie Niki, Satoshi Tetsumoto, Kazuhiko Hayashi, Kazumi Nishino, Izumi Nagatomo, Atsushi Kumanogoh. Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC. JTO Clinical and Research Reports. 2023 MAY;4(5):100505.(田宮朗裕)
- Miyashita K, Hozumi H, Inoue Y, Suzuki T, Suda T. Nationwide survey of adult patients with pulmonary alveolar proteinosis using the National Database of designated intractable diseases of Japan. Respiratory Investigation. 2023 MAY;61(3):364-370.(井上義一)
- Yoshihiko Taniguchi, Akihiro Tamiya, Atsushi Yanagisawa, Minako Shimaya, Mayu Kawakami, Yuji Inagaki, Nobuhiko Saijo, Yoshinobu Matsuda, Kyoichi Okishio. Cerebral infarction after treatment with dabrafenib plus trametinib for BRAF-V600E-positive non-small cell lung cancer: A case report. Thoracic cancer. 2023 MAY;14(13):1201-1203.(谷口善彦)
- Peljto AL, Blumhagen RZ, Walts AD, Cardwell J, Powers J, Corte TJ, Dickinson JL, Glaspole I, Moodley YP, Vasakova MK, Bendstrup E, Davidsen JR, Borie R, Crestani B, Dieude P, Bonella F, Costabel U, Gudmundsson G, Donnelly SC, Egan J, Henry MT, Keane MP, Kennedy MP, McCarthy C, McElroy AN, Olaniyi JA, O'Reilly KMA, Richeldi L, Leone PM, Poletti V, Puppo F, Tomassetti S, Luzzi V, Kokturk N, Mogulkoc N, Fiddler CA, Hirani N, Jenkins RG, Maher TM, Molyneaux PL, Parfrey H, Braybrooke R, Blackwell TS, Jackson PD, Nathan SD, Porteous MK, Brown KK, Christie JD, Collard HR, Eickelberg O, Foster EE, Gibson KF, Glassberg M, Kass DJ, Kropski JA, Lederer D, Linderholm AL, Loyd J, Mathai SK, Montesi SB, Noth I, Oldham JM, Palmisciano AJ, Reichner CA, Rojas M, Roman J, Schluger N, Shea BS, Swigris JJ, Wolters PJ, Zhang Y, Prele CMA, Enghelmayer JI, Otaola M, Ryerson CJ, Salinas M, Sterclova M, Gebremariam TH, Myllärniemi M, Carbone RG, Furusawa H, Hirose M, Inoue Y, Miyazaki Y, Ohta K, Ohta S, Okamoto T, Kim DS, Pardo A, Selman M, Aranda AU, Park MS, Park JS, Song JW, Molina-Molina M, Planas-Cerezales L, Westergren-Thorsson G, Smith AV, Manichaikul AW, Kim JS, Rich SS, Oelsner EC, Barr RG, Rotter JI, Dupuis J, O'Connor G, Vasan RS, Cho MH, Silverman EK, Schwarz MI, Steele MP, Lee JS, Yang IV, Fingerlin TE, Schwartz DA, Nhlbi Trans Omics Precision Med. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. American Journal of Respiratory and Critical Care Medicine. 2023 45413;207(9):1194-1202.(広瀬雅樹)
- Yamaguchi T, Matsunuma R, Matsuda Y, Tasaki J, Ikari T, Miwa S, Aiki S, Takagi Y, Kiuchi D, Suzuki K, Oyamada S, Ariyoshi K, Kihara K, Mori M. Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2023 MAY;65(5):400-408.(松田能宣)
- Tachibana K, Akira M, Arai T, Sugimoto C, Hayashi S, Inoue Y. Poor Outcome and Mortality in Patients with Lower Lung-Dominant Sarcoidosis. CANADIAN RESPIRATORY JOURNAL. 2023 45397;2023(Article ID 3624344):45299.(橘和延)
- Takimoto T, Sumikawa H, Arai T, Inoue Y. Left Vocal Cord Paralysis in Idiopathic Pleuroparenchymal Fibroelastosis: A Case Report. JMA Journal. 2023 45396;6(2):220-222.(滝本宜之)
- Megumu Osaki, Takehiko Kobayashi, Shiomi Yoshida, Shigeki Shimizu, Kazunari Tsuyuguchi. Mycobacterium avium Pleurisy with Bronchopleural Fistula Resulting in Rapidly Progressive Respiratory Failure Diagnosed by Transbronchial Autopsy. Internal medicine. 2023 APR;62(8):1237-1241.(吉田志緒美)
- Satoshi Tanizaki, Kinnosuke Matsumoto, Akihiro Tamiya, Yoshihiko Taniguchi, Yoshinobu Matsuda, Junji Uchida, Kiyonobu Ueno, Hayato Kawachi, Motohiro Tamiya, Takafumi Yanase, Hidekazu Suzuki, Kyoichi Okishio. Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study. European journal of clinical pharmacology. 2023 APR;79(4):503-511.(田宮朗裕)
- Takeuchi S, Kubota K, Sugawara S, Teramukai S, Noro R, Fujikawa K, Hirose T, Atagi S, Minami S, Iida S, Kuraishi H, Aiba T, Minegishi Y, Matsumoto M, Seike M, Gemma A, Kawahara M. Standard versus low-dose nab-paclitaxel in previously treated patients with advanced non-small cell lung cancer: A randomized phase II trial (JMTO LC14-01). Cancer Medicine. 2023 Apr;12(8):9133-9143.(安宅信二)
- K. Morimoto; M. Nonaka; Y. Yamazaki; T. Nakagawa; J. Takahashi; K. Tsuyuguchi; S. Kitada; Z. Jumadilova; D. W. Yuen; M. Ciesielska; N. Haasegawa. Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study. Respiratory Investigation. 2024 MAR;62(2):284-290.(露口一成)
- Akihiro Tamiya, Motohiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Yoshinobu Matsuda, Takahisa Kawamura, Kei Kunimasa, Takako Inoue, Kazumi Nishino, Kyoichi Okishio. Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting. Anticancer Research. 2023 MAR;43(3):1325-1330.(田宮朗裕)
- Kagawa T, Nagano H, Iwasaku M, Kawano R, Hirayama Y, Uraguchi K, Yoshioka T. Gastroesophageal Reflux Disease or Proton Pump Inhibitor Use?: A Controversy Over the Association of Nontuberculous Mycobacterial Pulmonary Disease. Chest. 2023 MAR;3(163):e147-e148.(香川智子)
- Daichi Fujimoto, Satoru Miura, Keisuke Tomii, Hiromitsu Sumikawa, Kenichi Yoshimura, Kazushige Wakuda, Yuko Oya, Toshihide Yokoyama, Takashi Kijima, Tetsuhiko Asao, Motohiro Tamiya, Atsushi Nakamura, Hiroshige Yoshioka, Takaaki Tokito, Shuji Murakami, Akihiro Tamiya, Hiroshi Yokouchi, Satoshi Watanabe, Ou Yamaguchi, Ryotaro Morinaga, Takayuki Jodai, Kentaro Ito, Yoshimasa Shiraishi, Yoshihito Kogure, Ryota Shibaki, Nobuyuki Yamamoto. Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer. Scientific reports. 2023 Mar;13(1):3698.(田宮朗裕)
- Toru Arai, Masaki Hirose, Tomoko Kagawa, Kazuyoshi Hatsuda, Yoshikazu Inoue. Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation. Journal of Thoracic Disease. 2023 FEB;15(2):300-310.(新井徹)
- Kensuke Kanaoka, Akihiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Maiko Takeda, Yoshinobu Matsuda, Kyoichi Okishio, Shigeki Shimizu. Possible False Results With cobas® EGFR Mutation Test v2 and Oncomine Dx Target Test for EGFR Mutation. Anticancer Research. 2023 JUN;43(6):2771-2776.(金岡賢輔)
- Kensuke Kanaoka, Shoich Fukuda, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Akihiro Tamiya, Yoshinobu Matsuda, Kyoichi Okishio. Right-sided vocal cord paralysis following stereotactic body radiation therapy for non-small-cell lung cancer: A case report. Thoracic cancer. 2023 JUN;14(16):1534-1537.(金岡賢輔)
和文原著・著書等
1. 松田能宣.非がん性呼吸器疾患の緩和ケア. 日本内科学会雑誌. 2024;112(3):531-536.
2. 露口一成.結核医療に関する課題. 結核医療の基準とその解説. 2024;
3. 新井徹.呼吸器ジャーナル「慢性間質性肺炎を呈する膠原病の急性増悪の診断と治療」. 膠原病内科 呼吸器内科とリウマチ膠原病内科、見えている景色はどう違うか?. 2024;
4. 茂田光弘.治りにくい肺炎に出会ったときに疑うべき鑑別診断. 臨床雑誌 内科. 2024;133(2):193-7.
5. 田中悠也,倉原優.病気のはなし 結核. 検査と技術. 2024;52(2): 124-128.
6. 新井徹.急性増悪の臨床病態と予後1)特発性肺線維症. 呼吸器内科. 2024;45(1):6~14.
7. 谷向仁,井上真一郎,松田能宣.がん患者におけるせん妄ガイドライン2022年版 -2019年版からの改定ポイントと今後の取り組みについて-. 腫瘍内科. 2024;33(1):65-70.
8. 倉原優.「結核の統計2023」を読み解く. J-IDEO. 2024;8(1):89-91.
9. 倉原優.クロファジミンの処方例が増えてきた. J-IDEO. 2024;8(2):321-323.
10. 合屋将,中野泰,十九浦宏明,高木雄亮,渡邊紘章,松田能宣,角甲純,笠原庸子,小原弘之,森雅紀,中山健夫,山口崇.低酸素血症があり呼吸困難を有する進行性疾患患者に対する高流量鼻カニュラ酸素療法の有効性 システマティックレビュー(原著論文). Palliative Care Research. 2023;18(4):261-269.
11. 西原昂.A Technical Manual of Bronchial Artery Embolization by Coil for Pulmonologists: An Expert's Opinion 呼吸器科医のためのコイルによる気管支動脈塞栓術の技術マニュアル:専門家の意見.Respiratory Endoscopy(一般社団法人 日本呼吸器内視鏡学会). 2023;1(2):28-41.
12. 倉原優.Aspiration Pneumonitis Caused by Gargling with 10% (w/v) Benzalkonium Chloride Proven by Mixing with an Anionic Surfactant 10%(w/v)塩化ベンザルコニウムを用いたうがいによる誤えん性肺炎が,陰イオン界面活性剤と混合することによって証明された1例. Respiratory Endoscopy(一般社団法人 日本呼吸器内視鏡学会). 2023;1(2):75-77.
13. 新井徹.希少疾患. 呼吸器内科学レビュー2024-2025(総合医学社). 2023;
14. 鮫島弘睦.Thoracoscopic sublobar resection for congenital bronchial atresia in adults: a report of three cases. General Thoracic and Cardiovascular Surgery Cases. 2023;
15. 奥田有香麻酔科,栗山俊之,月山淑,松田能宣,山口崇,森雅紀,下川敏雄,川股知之.呼吸困難のコントロールがオピオイドのみでは難しくミダゾラムを併用した終末期がん患者の要因(原著論文). Palliative Care Research. 2023;8(4):247-252.
16. 倉原優.あなどるなかれアミノグリコシドの難聴. J-IDEO. 2023;7(6):896-897.
17. 井上義一.リンパ脈管筋腫症(私の治療). WEB医事新報. 医事新報社. 2023;
18. 松田能宣.身体疾患にともなう抑うつ,不安 呼吸器疾患にともなう抑うつ,不安. 心身医学. 2023;63(6):520-524.
19. 倉原優.Survival 35 喘息発作・COPD増悪のときの全身性ステロイドはいつまで使えばいいの? 研修医サバイバルブック. 2023;
20. 田中悠也,今尾舞,難波晃平,藤本佑樹,池内美貴,山本浩生,橋田恵佑,久米佐知枝,稲尾崇,門田和也,大塚浩二郎,鈴木雄二郎,伊藤利江子,大林千穂.粘液栓の除去のみで軽快したScedosporium apiospermumによるアレルギー性気管支肺真菌症が疑われた1例. アレルギー2023;72(8):1051-1056.
21. 西原昂,石川秀雄.喀血. 救急医学. 2023;47(9):1074-1080.
22. 倉原優.コロナ禍で活躍したハイフロー酸素療法. J-IDEO. 2023;7(5):718-719.
23. 西原昂,石川秀雄.喀血. 救急医学. 2023;47(9):1074-1080.
24. 井上義一. ガイドラインから見るびまん性肺疾患診療の進歩. 肺胞蛋白症診療ガイドライン 2022. ガイドラインから見るびまん性肺疾患診療の進歩. 肺胞蛋白症診療ガイドライン 2022. 2023;44.
25. 井上義一.第5回X線動態画像セミナー総評. インナービジョンP. 2023;12.
26. 丸岡秀一郎,松田能宣,權寧博.ストレス性呼吸器障害をめぐって. 呼吸器内科. 2023;44(2):137-138.
27. 松田能宣.緩和医療とストレス性呼吸障害. 呼吸器内科. 2023;44(2):174-177.
28. 大西幸代.結核におけるリハビリテーションの現状. 医療. 2023;77(4):275-279.
29. 倉原優.薬剤性咳嗽. 呼吸器内科. 2023;44(1):47-52.
30. 倉原優.肺非結核性抗酸菌症 治療指針が11年ぶりに改訂 主要3菌種のポイント. Medical Tribune. 2023;56(15):7.
31. 倉原優.急増する肺非結核性抗酸菌(NTM)症にそなえよ. J-IDEO. 2023;7(4):476-491.
32. 倉原優.アスペルギルス属はなぜアゾール耐性になるのか?. J-IDEO. 2023;7(4):570-581.
33. 倉原優.Book Review シン・感染症999の謎. J-IDEO. 2023;7(4):562.
34. 松田能宣.ようこそ緩和ケアの森 がん・非がん患者の呼吸器症状を診る. 2023;
35. 倉原優.コロナ禍で悩ましい咳をなくしたい. 医療のトリセツ: 36人の専門家が本気で考えたやさしい医療のカタチ. 2023;
36. 所昭宏.不眠のケア. 消化器ナーシング,特集 病態と症状をキソからおさらい! 消化器がんの緩和ケア イラストガイド ; 症状別ケア編. 2023;28(7):673-677.
37. 松田能宣.COPD/間質性肺疾患の呼吸困難に対する症状緩和薬物療法. 進行性疾患患者の呼吸困難の緩和に関する診療ガイドライン2023年版. 2023;86-88.
38. 鮫島弘睦.自然退縮を認めた肺大細胞癌の1例. 肺癌 Japanese journal of Lung Cancer. 2023;63(3):268.
39. 松田能宣.難治性せん妄に対する緩和ケア. がん患者の治療抵抗性の苦痛と鎮静に関する基本的な考え方の手引き2023. 2023;45-56.
40. 松田能宣.これからはじめる非がん患者の緩和ケア第2版. 2023;
41. 澄川裕充.特発性間質性肺炎 特発性肺線維症と進行性肺線維症. 臨床画像. 2023;39(5):494-501.
42. 倉原優.第II章. 結核、非結核性抗酸菌症. 薬剤師のための感染制御マニュアル. 2023;
43. 倉原優.Chapter 6「呼吸器系」. 救急外来 オススメ処方・ダメ処方. 2023;
44. 倉原優、木村仁、大槻登季子、嶋谷泰明、篠原莉奈、雲依美里、藤原綾子、露口一成.結核病棟におけるCOVID-19のアウトブレイク報告. 結核. 2023;98(3):79-84.
45. 倉原優.結核病棟におけるCOVID-19のアウトブレイク報告. 結核. 2023;98(3):78-94.
46. 倉原優.CASE4 COPD. medicina. 2023;60(6):824-9.
47. 倉原優.慢性呼吸器感染症に対する吸入抗菌薬. J-IDEO. 2023;7(3):386-387.
48. 倉原優.ポケット呼吸器診療2023. 2023;
49. 倉原優.2023年新見解に基づく肺MAC症治療とアミカシンリポソーム吸入用懸濁液. medicina. 2023;61(3):480-485.
50. 岡田全司,喜多洋子,露口一成.第2章In vivo遺伝子治療 第5節 感染症in vivo遺伝子治療 2.結核ワクチン. 遺伝子治療開発研究ハンドブック第2版. 2023;489-496.
51. 日本呼吸器学会監修.井上義一(作成委員).特発性肺線維症の治療ガイドライン2023改訂第2版. 特発性肺線維症の治療ガイドライン2023改訂第2版. 2023;